GOETTINGEN, Germany & ST. LOUIS, Mo.--(BUSINESS WIRE)--Sartorius Stedim Biotech (Paris:DIM), and SAFC Biosciences, a business segment of SAFC and member of the Sigma-Aldrich group (Nasdaq:SIAL), both leading suppliers to the biopharmaceutical industry, announced the signing of a global partnership agreement that combines Sartorius Stedim Biotech’s (SSB) expertise in filtration and liquid handling systems with SAFC Biosciences’ proficiency in development and manufacturing of cell culture media and downstream purification products. The alliance is expected to provide more robust and comprehensive solutions to biopharmaceutical manufacturers.
